Bausch Health et Glenmark annoncent l'approbation du RYALTRIS MD au Canada Canada NewsWire LAVAL, QC, et...
Bausch Health Announces Early Exchange Offer Results for Exchange Offers and Consent Solicitations Canada...
Bausch Health Responds to Norwich Pharmaceuticals Tentative FDA Approval for a 200 mg Rifaximin PR...
Bausch Health Clarifies Release Provisions Related to its Exchange Offers and Consent Solicitations Canada...
S&P Dow Jones Indices annonce des modifications à l'indice composé S&P/TSX et à l'indice S&P/TSX 60 Canada...
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index and S&P/TSX 60 Index Canada NewsWire TORONTO, Sept. 2, 2022...
Bausch Health Announces Exchange Offers and Consent Solicitations for Certain Existing Senior Notes with...
Bausch Health Continuing Process Toward Separating Bausch + Lomb Canada NewsWire LAVAL, QC, Aug. 22, 2022...
Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit PR...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.